SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062125
Filing Date
2023-11-09
Accepted
2023-11-09 16:28:31
Documents
66
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q harp-20230930.htm   iXBRL 10-Q 3146980
2 EX-31.1 harp-ex31_1.htm EX-31.1 13097
3 EX-31.2 harp-ex31_2.htm EX-31.2 13088
4 EX-32.1 harp-ex32_1.htm EX-32.1 11101
  Complete submission text file 0000950170-23-062125.txt   10391509

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT harp-20230930.xsd EX-101.SCH 58797
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT harp-20230930_def.xml EX-101.DEF 226245
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT harp-20230930_pre.xml EX-101.PRE 365080
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT harp-20230930_lab.xml EX-101.LAB 489631
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT harp-20230930_cal.xml EX-101.CAL 46121
60 EXTRACTED XBRL INSTANCE DOCUMENT harp-20230930_htm.xml XML 1887378
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38800 | Film No.: 231393010
SIC: 2836 Biological Products, (No Diagnostic Substances)